Physician profile
Andrew Gorman
NPI 1265403513
$15,436.68
in general payments reported to CMS, 2019-2025
70 companies · $4,068 in 2025
The $4,068 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $377 · 2021: $1,194 · 2022: $2,354 · 2023: $2,960 · 2024: $3,493 · 2025: $4,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,312.96 |
| Education | $207.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,544.10 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Ucb, INC. | $1,534.18 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Abbvie INC. | $1,259.64 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $1,159.75 | 2019-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $761.34 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $613.48 | 2019-2025 | Rytary, Crexont |
| Biogen, INC. | $582.79 | 2019-2025 | Vumerity, Tysabri |
| Argenx US, INC. | $580.86 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Sk Life Science, INC. | $526.48 | 2022-2025 | |
| Mdd US Operations, LLC | $509.47 | 2019-2025 | Apokyn, Apokyn, Gocovri |
| Alexion Pharmaceuticals, INC. | $495.08 | 2019-2025 | Ultomiris |
| Eisai INC. | $463.09 | 2019-2025 | |
| Genentech USA, INC. | $404.55 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Celgene Corporation | $380.73 | 2023-2025 | Zeposia |
| Emd Serono, INC. | $346.92 | 2022-2025 | Mavenclad |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.